Directorate Change

Summary by AI BETAClose X

HUTCHMED announced that Executive Director Dr. Weiguo Su will take a leave of absence from his role as Chief Executive Officer due to health reasons. Effective immediately, Executive Director and Chief Financial Officer Mr. Johnny Cheng has been appointed as Acting Chief Executive Officer, in addition to his current responsibilities. Mr. Cheng's director's fees are US$70,000 per annum, with an additional US$5,000 for his role on the Sustainability Committee. His emoluments as Chief Financial Officer include a US$490,513 annual salary, a discretionary bonus, and up to US$779,934 per annum in equity compensation. As of the announcement, Mr. Cheng has a personal interest in 2,936,430 ordinary shares, representing approximately 0.34% of the issued shares.

Disclaimer*

UK 100

Latest directors dealings